Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Download Library Categories - Any -Annual ReportsCorporate OverviewDefault CalendarDisclosure DocumentsGovernanceInvestor ConferenceMergerMerger News ReleasesPFIC Annual InformationQuarterly Reports Year None202120202018201720162015201420132012201120102009 Corporate Governance Guidelines Corporate Governance and Nominating Committee Charter Insider Trading Policy Audit Committee Charter Whistleblower Policy Code of Business Conduct Related Persons Transactions Policy Executive Compensation and Human Resources Committee Charter 2017 Annual Report (Form 10-K) A Phase 2a Study Evaluating the Multi-dose Activity of ARB-1467 in HBeAg Positive and HBeAg Negative Virally Suppressed Subjects with Hepatitis B 2016 Annual Report (Form 10-K) 2015 Annual Report (Form 10-K) 2014 Annual Report (Form 10-K) Presentation – Feb 11 2015 Press Release – Feb 4 2015 Proxy Statement Notice of Special Meeting Presentation – Jan 12 2015 Press Release – Jan 11 2015 Conference Call Transcript – Jan 12 2015 Tekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company 2013 Annual Report (Form 10-K) Third Quarter 2013 Report Second Quarter 2013 Report First Quarter 2013 Report 2012 Annual Report Third Quarter 2012 Report Second Quarter 2012 Report First Quarter 2012 Report 2011 Annual Report 2011 Annual Report Form 20F - 2011 Annual Report Form 20F - 2011 Annual Report Third Quarter 2011 Report Second Quarter 2011 Report First Quarter 2011 Report 2010 Annual Report 2010 Annual Information Form (AIF) 2010 Third Quarter Report 2010 Second Quarter Report 2009 Annual Report 2008 Annual Report Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Download Library Categories - Any -Annual ReportsCorporate OverviewDefault CalendarDisclosure DocumentsGovernanceInvestor ConferenceMergerMerger News ReleasesPFIC Annual InformationQuarterly Reports Year None202120202018201720162015201420132012201120102009 Corporate Governance Guidelines Corporate Governance and Nominating Committee Charter Insider Trading Policy Audit Committee Charter Whistleblower Policy Code of Business Conduct Related Persons Transactions Policy Executive Compensation and Human Resources Committee Charter 2017 Annual Report (Form 10-K) A Phase 2a Study Evaluating the Multi-dose Activity of ARB-1467 in HBeAg Positive and HBeAg Negative Virally Suppressed Subjects with Hepatitis B 2016 Annual Report (Form 10-K) 2015 Annual Report (Form 10-K) 2014 Annual Report (Form 10-K) Presentation – Feb 11 2015 Press Release – Feb 4 2015 Proxy Statement Notice of Special Meeting Presentation – Jan 12 2015 Press Release – Jan 11 2015 Conference Call Transcript – Jan 12 2015 Tekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company 2013 Annual Report (Form 10-K) Third Quarter 2013 Report Second Quarter 2013 Report First Quarter 2013 Report 2012 Annual Report Third Quarter 2012 Report Second Quarter 2012 Report First Quarter 2012 Report 2011 Annual Report 2011 Annual Report Form 20F - 2011 Annual Report Form 20F - 2011 Annual Report Third Quarter 2011 Report Second Quarter 2011 Report First Quarter 2011 Report 2010 Annual Report 2010 Annual Information Form (AIF) 2010 Third Quarter Report 2010 Second Quarter Report 2009 Annual Report 2008 Annual Report
A Phase 2a Study Evaluating the Multi-dose Activity of ARB-1467 in HBeAg Positive and HBeAg Negative Virally Suppressed Subjects with Hepatitis B
Tekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company
